EirGen Pharma Limited Fair-Med Healthcare GmbH
PolandAll drugs from this manufacturer
-
This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the case of tumor regrowth or disease progression (e.g., malignant glioma or anaplastic astrocytoma).
Dosage form: capsules, hard
Active substance Dosage temozolomide 5 mg ATC: L01AX03
-
This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).
Dosage form: capsules, hard
Active substance Dosage temozolomide 20 mg ATC: L01AX03
-
This medicine is used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor recurrence or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).
Dosage form: capsules, hard
Active substance Dosage temozolomide 140 mg ATC: L01AX03
-
This is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is administered first in combination with radiotherapy, and later as monotherapy. In children over 3 years of age and in adults, it is used in cases of tumor regrowth or disease progression (e.g., malignant glioma or anaplastic astrocytoma).
Dosage form: capsules, hard
Active substance Dosage temozolomide 180 mg ATC: L01AX03
-
It is an anticancer medicine used in the treatment of brain tumors. In adults with newly diagnosed glioblastoma multiforme, it is used first in combination with radiotherapy, and then as monotherapy. In children over 3 years of age and in adults, it is used in the event of tumor regrowth or disease progression (e.g., glioblastoma multiforme or anaplastic astrocytoma).
Dosage form: capsules, hard
Active substance Dosage temozolomide 250 mg ATC: L01AX03